ELVN

-- -- --

Vol: -- Mkt Cap: --

Price Chart (30 Days)

Analyst Sentiment

100%

Bullish (2) Neutral (0) Bearish (0)

Latest ELVN News

Bullish

Enliven Therapeutics reports positive phase 1 CML data and FDA alignment for phase 3 trial (ELVN)

The article reports that Enliven Therapeutics has announced positive Phase 1 clinical trial data for its chronic myeloid leukemia (CML) treatment. The...

MSN 2 weeks ago 0

Bullish

Enliven Therapeutics prices upsized $400M public offering of common stock and pre-funded warrants

Enliven Therapeutics has priced an upsized public offering, raising $400 million through the sale of common stock and pre-funded warrants. This financ...